Join the Virginia Drug Discovery Consortium for their annual symposium!
VirginiaDrugDiscoveryRx: From Discovery to Development
Keynote Speakers:
Katherine Franz, PhD, Chair, Department of Chemistry at Duke University
Joe (Skip) Garcia, MD, Associate VP for Research at University of Florida Health Center
James L. Gulley MD/PhD, Director, Medical Oncology Service,National Cancer Institute
Sadis Matalon, PhD, Department of Anesthesiology at University of Alabama Birmingham
Jeffrey Schlom PhD, Co-Director, Center for Immuno-Oncology,National Cancer Institute
Jetze Tepe, PhD Director of Drug Discover, University of Virginia
Invited Speakers:
Stephanie Davis, PhD, NHLBI Small Business Program Coordinator
Umesh Desai, PhD Chair, Depatment of Medicial Chemistry, Virginia Commonwealth University
Jessica Gilbertie, PhD Microbiology and Immunology, VCOM; President/CEO Qenteros
Robert Gourdie, PhD Fralin Biomedical Research Institute; President Tiny Cargo
Shantá Hinton, PhD Department of Biology College of William and Mary
Kylene Kehn-Hall, PhD Department of Biomedical Sciences and Pathobiology, Virginia Tech
John Lazo, PhD Chief Scientific Officer with KeViRx
VaDDRx 2024 is presented in partnership with:
Along with additional sponsorship consideration from:
Thanks to our legacy sponsors for their continuing support!
Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
About Virginia Bio
The Virginia Biotechnology Association, formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and device industries before federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Innovation Organization (BIO), in Washington, D.C.